Compare SIDU & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIDU | SGMO |
|---|---|---|
| Founded | 2012 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.0M | 141.2M |
| IPO Year | 2021 | 2000 |
| Metric | SIDU | SGMO |
|---|---|---|
| Price | $4.37 | $0.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 28.4M | 6.6M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.94 | 10.20 |
| EPS | N/A | ★ N/A |
| Revenue | $3,383,878.00 | ★ $36,567,000.00 |
| Revenue This Year | $171.29 | $24.46 |
| Revenue Next Year | N/A | $193.67 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 88.60 |
| 52 Week Low | $0.63 | $0.21 |
| 52 Week High | $5.99 | $0.84 |
| Indicator | SIDU | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 56.46 | 42.07 |
| Support Level | $0.89 | $0.21 |
| Resistance Level | $4.40 | $0.55 |
| Average True Range (ATR) | 0.83 | 0.03 |
| MACD | 0.16 | 0.00 |
| Stochastic Oscillator | 59.02 | 65.19 |
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.